logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
CNS Drugs cover

CNS Drugs

IF7.4
Papers2461
Citations6974
Journal Papers 2547
Publication Date
delete
A Phase 3, Multicenter, Randomized, Placebo-Controlled Trial Evaluating the Efficacy, Safety, and Tolerability of Serdexmethylphenidate/d-Methylphenidate Capsules in Chinese Children with Attention-Deficit/Hyperactivity Disorder
deleteCNS Drugs
IF7.4
delete2026-10-04
delete0
PREAI
deleteJing Liu; Ying Yang; Yi Wang; Jinjin Chen; Rongwang Yang; Yonghua Cui; Lili Zhang; Wenjing Liu; Fan He; Li Yang; Defeng Xu; Jinhua Sun; Aidina Aisikeer; Xiaoli Fan; Jingran Liu; Lei Wang; Zhengqi Sun; Tan Jia; Jun Qi; Jim Z. Wu; Yi Zheng
deleteShare
deleteSave
Cognitive Effects of Cenobamate as Compared to Perampanel: A Cross-Sectional Multicentre Study in 600 Patients
deleteCNS Drugs
IF7.4
delete2026-10-02
delete0
deleteOAAI
deleteJuri-Alexander Witt; Judit Catalán-Aguilar; Elisa Schütz; Randi von Wrede; Kevin G. Hampel; Yulia Novitskaya; Rainer Surges; Mercedes Garcés; Birgitta Metternich; Kathrin Wagner; Vicente Villanueva; Christoph Helmstaedter
deleteShare
deleteSave
Rozanolixizumab: A Review in AChR or MuSK Autoantibody-Positive Generalised Myasthenia Gravis
deleteCNS Drugs
IF7.4
delete2026-09-30
delete0
PREAI
deleteAisling McGuigan; Hannah A. Blair
deleteShare
deleteSave
Eculizumab and Ravulizumab During Pregnancy in Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis: Balancing Maternal Disease Control and Fetal Safety
deleteCNS Drugs
IF7.4
delete2026-09-30
delete0
PREAI
deleteEva Dhupia; Jennifer A. McCombe; Sean J. Pittock; Nabeela Nathoo
deleteShare
deleteSave
Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials
deleteCNS Drugs
IF7.4
delete2026-09-23
delete0
deleteOAAI
deleteItai Danovitch; Kyla Truman; Haze Brown; Macie Miller; Shaishav Shah; Jayant Totlani; Daniel N. Kaidbay; Kaleab K. Tessema; Zholi Minasyan; Waguih William IsHak; Samuel Miles; Robert N. Pechnick
deleteShare
deleteSave
From Proof of Principle to Therapeutic Discipline: Strategies to Improve the Benefit/Risk Profile of Amyloid-Targeting Treatments for Alzheimer’s Disease
deleteCNS Drugs
IF7.4
delete2026-09-15
delete0
deleteOAAI
deleteRobert Perneczky; Frank Jessen; Timo Grimmer; Johannes Levin; Anna Hufnagel; Agnes Flöel; Oliver Peters; Lutz Froelich; Anna Hofmann
deleteShare
deleteSave
Bistromathics in Epilepsy and the Relativity of Numbers
deleteCNS Drugs
IF7.4
delete2026-09-11
delete0
PREAI
deleteEmilio Russo; Roberta Roberti; Eugen Trinka
deleteShare
deleteSave
Cognitive Side Effects of Antiseizure Medications in Adults with Epilepsy: An Update with a Focus on New Therapeutic Agents
deleteCNS Drugs
IF7.4
delete2026-09-09
delete0
PREAI
deleteMarco Mula
deleteShare
deleteSave
Correction: Efficacy and Safety of an Early Aggressive Lipid‑Lowering Strategy Using Triple Therapy After Mechanical Thrombectomy
deleteCNS Drugs
IF7.4
delete2026-09-04
delete0
PREAI
deleteHo Geol Woo; Jaeyu Park; Tae-Jin Song; Mi-Yeon Eun; Heejung Mo; Hee-Kwon Park
deleteShare
deleteSave
Next-Generation Pharmacotherapies for Unipolar Mood Disorders: A Leading Article on Phase II/III Drug Development Across Diverse Mechanisms
deleteCNS Drugs
IF7.4
delete2026-08-26
delete0
PREAI
deleteAlana King; Morgan Hardy; Taeho Greg Rhee; Samuel T. Wilkinson
deleteShare
deleteSave
Opioid Add-On Combination Therapy for Cancer Pain: Pharmacological Rationale, Clinical Evidence, and Future Directions
deleteCNS Drugs
IF7.4
delete2026-08-26
delete0
PREAI
deleteSebastiano Mercadante
deleteShare
deleteSave
Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis
deleteCNS Drugs
IF7.4
delete2026-08-13
delete0
PREAI
deleteShakila Meshkat; Marco Leung; Sarina Meshkat; Qiaowei Lin; Dillani Wijendran; Amy C. Reichelt; Yanbo Zhang; Lisa Burback; Olga Winkler; Andrew Greenshaw; Candice M. Monson; Eric Vermetten; Rakesh Jetly; Wendy Lou; Richard J. Zeifman; Venkat Bhat
deleteShare
deleteSave
Candidate Clinico-Demographic Predictors or Moderators of Efficacy and Tolerability of Pharmacological Treatment in Attention-Deficit/Hyperactivity Disorder (ADHD): An Analysis of the MED-ADHD Repository of Randomised Controlled Trials
deleteCNS Drugs
IF7.4
delete2026-08-13
delete0
PREAI
deleteSulagna Roy; Guilherme Fusetto Veronesi; Sara Mannarini; Daniele Pirolo; Alessio Bellato; Samuele Cortese; Valeria Parlatini
deleteShare
deleteSave
Heterogeneity in Teriflunomide Treatment Arms: A Systematic Review and Meta‑Regression of Randomised Multiple Sclerosis Trials
deleteCNS Drugs
IF7.4
delete2026-08-12
delete0
PREAI
deleteFrancesca Bovis; Alessio Signori; Mirko Capanna; Noemi Montobbio; Maria Pia Sormani
deleteShare
deleteSave
Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study
deleteCNS Drugs
IF7.4
delete2026-08-07
delete0
deleteOAAI
deleteChiranth Bhagavan; Olivia Carter; Glenn Nielsen; David Berlowitz; Sara Issak; Sabine Braat; Sophie Zaloumis; Zachary Attard; Gina Oliver; Deanne Mayne; James Rucker; Matthew Butler; Orwa Dandash; Alexander Bryson; Richard A. Kanaan
deleteShare
deleteSave
Sigma-1 Receptor Ligand Blarcamesine (ANAVEX 2-73) for Alzheimer’s Disease: A Systematic Review
deleteCNS Drugs
IF7.4
delete2026-08-06
delete0
PREAI
deleteSirikalaya Brimson; Premrutai Thitilertdecha; Kishoree Krishna Kumaree; James Michael Brimson
deleteShare
deleteSave
Efficacy and Safety of an Early Aggressive Lipid-Lowering Strategy Using Triple Therapy After Mechanical Thrombectomy
deleteCNS Drugs
IF7.4
delete2026-08-03
delete0
PREAI
deleteHo Geol Woo; Jaeyu Park; Tae-Jin Song; Mi-Yeon Eun; Heejung Mo; Mo; Hee-Kwon Park
deleteShare
deleteSave
PDE10A Inhibition in Schizophrenia: A Randomised, Placebo-Controlled Phase 2 Study of Alofropodect (CPL’36) in Patients Experiencing Acute Schizophrenia
deleteCNS Drugs
IF7.4
delete2026-07-31
delete0
deleteOAAI
deleteMaciej Wieczorek; Napoleon Waszkiewicz; Ewa Gromniak-Haniecka; János M. Réthelyi; Mykhaylo Pustovoyt; Yuriy Filts; Yuliya Blazhevych; Mikołaj Matłoka; Sylwia Janowska; Barbara Łapińska; Piotr J. Rudzki; Radosław Jaźwiec; Joanna Sierzputowska-Prarat
deleteShare
deleteSave
Comparative Bioavailability of Trimodal (CTx-1301) Versus Bimodal Dexmethylphenidate Modified-Release Formulations in Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized, Single-Dose, Crossover Study
deleteCNS Drugs
IF7.4
delete2026-07-28
delete0
deleteOAAI
deleteArthur B. Straughn; Raul Silva; Michael J. Cattaneo; Kelly Koehn; Matthew Brams
deleteShare
deleteSave
Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence
deleteCNS Drugs
IF7.4
delete2026-07-28
delete0
deleteOAAI
deleteRoger S. McIntyre; Masaki Kato; Michael E. Thase; François Therrien; A. Marilise Marrache; Kenta Ikehara; Ferhat Ardic; Matthieu Boucher
deleteShare
deleteSave